Ery-Ped is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals). The primary component is Erythromycin Ethylsuccinate.
Product ID | 24338-132_084f4439-0824-4419-9d4b-26916d0850b4 |
NDC | 24338-132 |
Product Type | Human Prescription Drug |
Proprietary Name | Ery-Ped |
Generic Name | Erythromycin Ethylsuccinate |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2011-07-05 |
Marketing Category | NDA / NDA |
Application Number | NDA050207 |
Labeler Name | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) |
Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
Active Ingredient Strength | 200 mg/5mL |
Pharm Classes | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2011-07-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050207 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-07-05 |
Ingredient | Strength |
---|---|
ERYTHROMYCIN ETHYLSUCCINATE | 200 mg/5mL |
SPL SET ID: | 04775721-ab87-4b66-808c-d67a21032385 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |